1. Home
  2. PFO vs ACOG Comparison

PFO vs ACOG Comparison

Compare PFO & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated

PFO

Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated

HOLD

Current Price

$9.06

Market Cap

118.5M

Sector

Finance

ML Signal

HOLD

Logo Alpha Cognition Inc.

ACOG

Alpha Cognition Inc.

N/A

Current Price

$5.99

Market Cap

110.4M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
PFO
ACOG
Founded
1991
2000
Country
United States
Canada
Employees
N/A
57
Industry
Finance Companies
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
118.5M
110.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PFO
ACOG
Price
$9.06
$5.99
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$16.00
AVG Volume (30 Days)
36.1K
33.9K
Earning Date
01-01-0001
05-14-2026
Dividend Yield
6.51%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$139.22
Revenue Next Year
N/A
$134.48
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.01
$4.50
52 Week High
$9.90
$10.88

Technical Indicators

Market Signals
Indicator
PFO
ACOG
Relative Strength Index (RSI) 36.53 47.54
Support Level $8.85 $5.73
Resistance Level $9.84 $6.48
Average True Range (ATR) 0.07 0.40
MACD -0.02 -0.02
Stochastic Oscillator 26.29 50.43

Price Performance

Historical Comparison
PFO
ACOG

About PFO Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated

Flaherty & Crumrine Prfd Income Oppo is the United States-based diversified, closed-end management investment company. Its primary investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Share on Social Networks: